The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Antibiotics for acute bronchitis
Open accessAbstract
BACKGROUND: Antibiotic treatment of acute bronchitis, which is one of the most common illnesses seen in primary care, is controversial. Most clinicians prescribe antibiotics in spite of expert recommendations against this practice. OBJECTIVES: The objective of this review was to assess the effects of antibiotic treatment for patients with a clinical diagnosis of acute bronchitis. SEARCH STRATEGY: In this updated review, we searched the Cochrane Central Register of Controlled trials (CENTRAL) (The Cochrane Library Issue 2, 2004); MEDLINE (January 1966 to March 2004); EMBASE (January 2000 to December 2003); SciSearch from 1989 to 2004; reference lists of articles and the authors' personal collections up to 1996, and also wrote to study authors and drug manufacturers. EMBASE has previously been searched from 1974 to 2000). SELECTION CRITERIA: Randomised controlled trials comparing any antibiotic therapy with placebo in acute bronchitis or acute productive cough without other obvious cause in patients without underlying pulmonary disease. DATA COLLECTION AND ANALYSIS: At least two reviewers extracted data and assessed trial quality. Authors were contacted for missing data. MAIN RESULTS: Nine trials involving over 750 patients aged eight to over 65 and including smokers and non-smokers were included in the primary analysis. The quality of the trials was variable. A variety of outcome measures were assessed. Overall, patients receiving antibiotics had better outcomes than did those receiving placebo. At a follow-up visit, they were less likely to have a cough (relative risk (RR) 0.64, 95% confidence interval (CI) 0.49 to 0.85; number-needed-to-treat (NNT) 5; 95% CI 3 to 14), show no improvement on physician assessment (RR 0.52; 95% CI 0.31 to 0.87; NNT 14; 95% CI 8 to 50), or have abnormal lung findings (RR 0.48; 95% CI 0.26 to 0.89; NNT 11; 95% CI 6 to 50); and had shorter durations of cough (weighted mean difference 0.58 days; 95% CI 0.01 to 1.16 days), productive cough (weighted mean difference (WMD) 0.52 days; 95% CI 0.01 to 1.03 days), and feeling ill (WMD 0.58 days; 95% CI 0.00 to 1.16 days). There were no significant differences regarding the presence of night cough, productive cough, or activity limitations at follow up, or in the mean duration of activity limitations. The benefits of antibiotics were less apparent in a sensitivity analysis that included data from two other studies of patients with upper respiratory tract infections with productive cough. There was a non significant trend towards an increase in adverse effects in the antibiotic group, relative risk (RR) 1.22 (95% CI 0.94 to 1.58). REVIEWERS' CONCLUSIONS: Overall, antibiotics appear to have a modest beneficial effect in patients who are diagnosed with acute bronchitis. The magnitude of this benefit, however, is similar to that of the detriment from potential adverse effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M. M., Huber, P. R., Tamm, M., & Müller, B. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15591-8 · Cited by 1,096
Gonzales, R. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550110039033 · Cited by 717
Egger, M., & Smith, G. D. (1995) · BMJ · doi:10.1136/bmj.310.6982.752 · Cited by 508
Metlay, J. P. (1997) · JAMA · doi:10.1001/jama.278.17.1440 · Cited by 438
Macfarlane, J. T., Macfarlane, R. M., Rose, D. H., Colville, A., & Guion, A. (1993) · The Lancet · doi:10.1016/0140-6736(93)90275-l · Cited by 399
Macfarlane, J. (2001) · Thorax · doi:10.1136/thorax.56.2.109 · Cited by 333
Metlay, J. P., Kapoor, W. N., & Fine, M. J. (1997) · JAMA · doi:10.1001/jama.1997.03550170070035 · Cited by 314
Petersen, I., Johnson, A. M., Islam, A., Duckworth, G., Livermore, D. M., & Hayward, A. C. (2007) · BMJ · doi:10.1136/bmj.39345.405243.be · Cited by 304
Foy, H. M. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.supplement_1.s37 · Cited by 299
Evidence that Chlamydia pneumoniae Causes Pneumonia and Bronchitis
Grayston, J. T., Aldous, M. B., Easton, A., Wang, S.-P., Kuo, C.-C., Campbell, L. A., & Altman, J. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/168.5.1231 · Cited by 278
Cited by
Llor, C., & Bjerrum, L. (2014) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098614554919 · Cited by 2,079
Guidelines for the management of adult lower respiratory tract infections - Full version
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03672.x · Cited by 942
Cals, J. W. L., Butler, C. C., Hopstaken, R. M., Hood, K., & Dinant, G.-J. (2009) · BMJ · doi:10.1136/bmj.b1374 · Cited by 498
Little, P., Stuart, B., Francis, N., Douglas, E., Tonkin-Crine, S., Anthierens, S., Cals, J. W., Melbye, H., Santer, M., Moore, M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60994-0 · Cited by 430
Antibiotics for the common cold and acute purulent rhinitis
Kenealy, T., & Arroll, B. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000247.pub3 · Cited by 431
Metadata
- Authors
- Smith, S. M., Fahey, T., Smucny, J., & Becker, L. A.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2004-10-18
- Volume
- 6
- Issue
- 4
- Pages
- CD000245-CD000245
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W2088012039
- Cited by
- 267
- References
- 49
- Type
- reference entry
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antibiotics for acute bronchitis. https://app.cochat.ai/papers/10.1002/14651858.cd000245.pub2
- The paper
- Smith, S. M., Fahey, T., Smucny, J., & Becker, L. A. (2004). Antibiotics for acute bronchitis. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd000245.pub2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.